These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Basics: Excipients Used in Nonsterile Compounding, Part 1. Allen LV Int J Pharm Compd; 2019; 23(4):305-311. PubMed ID: 31315082 [TBL] [Abstract][Full Text] [Related]
26. Choosing a medication brand: Excipients, food intolerance and prescribing in older people. Page A; Etherton-Beer C Maturitas; 2018 Jan; 107():103-109. PubMed ID: 29169573 [TBL] [Abstract][Full Text] [Related]
28. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients. Jorgensen L; Hostrup S; Moeller EH; Grohganz H Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792 [TBL] [Abstract][Full Text] [Related]
29. Impact of presence of excipients in drug analysis in fed-state gastric biorelevant media. Baxevanis F; Kuiper J; Fotaki N Eur J Pharm Biopharm; 2018 Oct; 131():178-188. PubMed ID: 30110669 [TBL] [Abstract][Full Text] [Related]
30. Basics of compounding foam dosage forms. Allen LV Int J Pharm Compd; 2013; 17(4):312-22. PubMed ID: 24261147 [TBL] [Abstract][Full Text] [Related]
31. Computational Characterization of Antibody-Excipient Interactions for Rational Excipient Selection Using the Site Identification by Ligand Competitive Saturation-Biologics Approach. Jo S; Xu A; Curtis JE; Somani S; MacKerell AD Mol Pharm; 2020 Nov; 17(11):4323-4333. PubMed ID: 32965126 [TBL] [Abstract][Full Text] [Related]
32. From single excipients to dual excipient platforms in dry powder inhaler products. Shur J; Price R; Lewis D; Young PM; Woollam G; Singh D; Edge S Int J Pharm; 2016 Dec; 514(2):374-383. PubMed ID: 27262269 [TBL] [Abstract][Full Text] [Related]
33. Biologic excipients: Importance of clinical awareness of inactive ingredients. Ionova Y; Wilson L PLoS One; 2020; 15(6):e0235076. PubMed ID: 32584876 [TBL] [Abstract][Full Text] [Related]
34. Insights into Novel Excipients of Self-Emulsifying Drug Delivery Systems and Their Significance: An Updated Review. Rani ER; Radha GV Crit Rev Ther Drug Carrier Syst; 2021; 38(2):27-74. PubMed ID: 33639067 [TBL] [Abstract][Full Text] [Related]
35. Miniaturized approach for excipient selection during the development of oral solid dosage form. Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033 [TBL] [Abstract][Full Text] [Related]
36. The impact of common pharmaceutical excipients on the gut microbiota. Subramaniam S; Kamath S; Ariaee A; Prestidge C; Joyce P Expert Opin Drug Deliv; 2023; 20(10):1297-1314. PubMed ID: 37307224 [TBL] [Abstract][Full Text] [Related]
38. Quality Control: Testing for "Micromonsters": Viable Air and Surface Sampling in Aseptic Compounding. Mulder K Int J Pharm Compd; 2021; 25(3):211-216. PubMed ID: 34125711 [TBL] [Abstract][Full Text] [Related]
39. Basics of compounding: basics of compounding with aliquots, dilutions, and concentrates. Allen LV Int J Pharm Compd; 2010; 14(6):508-10. PubMed ID: 23965655 [TBL] [Abstract][Full Text] [Related]
40. Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets. Liew KB; Hii SH; Chew YL; Ming LC; Uddin AH; Sarker ZI Int J Pharm Compd; 2022; 26(3):255-263. PubMed ID: 35657749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]